All Posts

Are you an experienced nursing academic with a strong record in teaching, research, and academic leadership? Do you want to help shape the future nursing workforce in Aotearoa through research-informed education, innovation, and collaboration with the health sector? This is an exciting opportunity to join the School of Nursing and Midwifery at the University of Waikato and contribute to the development of a highly skilled, culturally responsive nursing workforce. Ngā kōrero m

Leadership opportunity for an experienced Registered Nurse in mental health $105,812 + complexity allowance + 5 weeks AL + 2 paid well-being days HealthNow Payment Card - $250 per year + Increased KiwiSaver contribution    Great leadership opportunity - Registered Nurse with experience in mental health to lead our Nelson based Respite service.   What we offer | Ngā āhuatanga kei a mātou   $105,812 + complexity allowance Increased Kiwisaver contribution Fifth week of Annual Le

Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 13 March 2026. It includes information on:  New updates Resolved Supply Issues Supply issue: hydrocortisone 5mg + cinchocaine 5mg (Proctosedyl) Suppositories An expected shipment has been delayed. This has resulted in a supplier out of stock of Proctosedyl suppositories. Proctosedyl ointment is available. Ultraproct suppositories have been out of st

Hurry and secure your place this weekend We invite all primary care professionals to New Zealand’s premier professional development event for general practice and primary care. Event Overview: 📅 March 2026 21-22 Due Drop Events Centre, Manukau Programme highlights : Hear from leading experts and our partners the Royal NZ College of GPs, the Royal NZ College of Urgent Care, and Allevia Hospitals - with a line-up that blends essential updates, fresh perspectives, and practice-

New medicine supply notices Flumetasone pivalate (Locorten-Vioform) ear drops (Pharmacode 259799) There will be an out of stock until at least August 2026. The alternatives are Kenacomb (Pharmcode: 253634) and Sofradex (a part charge applies to Sofradex) (Pharmacode: 208728). Sodium Fusidate [fusidic acid] (Foban) Oint 2% (Pharmacode 2556189) The ointment may go out of stock. There is ample supply of the cream (Pharmacode: 2556170) to use as an alternative. Updated medicine

The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the Regulations) set the minimum quality standard that medicinal cannabis products and ingredients must meet before they can be supplied in New Zealand. Importers, manufacturers, and suppliers must apply for assessment and provide evidence to the Medicinal Cannabis Agency to verify that their products meet the minimum quality standard. Beacon Medical GSC THC20 CBD≤1 has been verified as meeting the minimum quality sta

Nurse Practitioner – Full or Part Time Residential Eldercare Services   🌟 Join Our Exceptional Team as a Nurse Practitioner! 🌟 Are you passionate about providing the highest standard of care to the elderly? Do you thrive in a collaborative and supportive work environment? We have an exciting job opportunity for Nurse Practitioners to join our unique totally mobile general practice dedicated to eldercare. At Residential Eldercare Services, we believe in fostering a dynamic a

From 1 July 2026, Pharmac will take over responsibility for funding medicines used in ambulances. This consultation seeks feedback on changes to the Pharmaceutical Schedule which supports this decision. Bringing ambulance medicines into the Pharmaceutical Schedule will help to ensure a more coordinated approach to funding and procurement decisions for emergency medicines, whether they are used in hospitals, ambulances or by PRIME providers. Under this proposal, we would also

We have made the decision to widen access to brentuximab vedotin for systemic anaplastic large cell lymphoma from 1 April 2026 .  We expect this will improve the lives of around 12-13 people in New Zealand per year.Thank you to all those who provided feedback in response to the consultation, your feedback is appreciated. You can find more information on this decision on the Pharmac website including our responses to key points raised by consultees. Decision to widen access to

Pharmac has made a decision to widen access to Trikafta and Kalydeco, and to fund Alyftrek for the treatment of cystic fibrosis.From 1 April 2026, the following changes will be implemented for people with eligible mutations: Widened access to Trikafta (elexacaftor/tezacaftor/ivacaftor) Widened access to Kalydeco (ivacaftor) Funding of a new medicine, Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) This decision follows consultation with people with cystic fibrosis, their fami

Dear Andrea, NEXT WEEK!  Goodfellow Symposium 2026 And while we wait, here are our latest webinars and podcasts:    Functional gastrointestinal conundrums: Utilising the MDT WEBINAR 17 March: The team from Allevia Hospitals will distil key practical tips and demonstrate how a team-based, multidisciplinary approach can help clinicians manage common GI conundrums more effectively.    Register here   Adult ADHD in practice: A clinical Q&A  WEBINAR 19 March: Join David Codyre for

Please see advert below:

Kia ora   Supply Issue:   We are writing to inform you that due to shipping delays, Sandoz expects to run out of ticagrelor 90mg tab by mid-March 2026.   Key Dates: It is estimated that ticagrelor 90mg tab (Sandoz) stock will be depleted by mid-March An alternative brand Ticagrelor Mylan 90mg tab was listed from 1 March 2026   Key messages: Ticagrelor Mylan is from the Italian market. The box will be over labelled with English text, and the blister packs have Italian text. Ti

Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 06 March 2026. It includes information on:  New updates Resolved Supply Issues Changes to antiretroviral dispensing – effective 1 March 2026 From 1 March 2026, all listed  antiretroviral  (Community Schedule)  treatments changed to 90‑day dispensing and may be prescribed and dispensed accordingly where appropriate.  Supply issue: ticagrelor tab 90 m

Please see Research Review edition attached

Please see Research Review edition attached

Pharmac has asked suppliers to notify us early of any supply risks, so we can act sooner and support ongoing access to medicines and medical devices. Read more Have your say We’re consulting on upcoming changes to how the Pharmaceutical Schedule will work. Changes to how the Pharmaceutical Schedule will work  (consultation closes 13 March 2026) New medicine supply notices   Proctosedyl (suppositories)  Unfortunately, AFT (the supplier) has run out of Proctosedyl suppositories

Pharmac is seeking feedback on a proposal to fund letermovir, a medicine that helps prevent serious viral infection in people with very weak immune systems. Under this proposal, letermovir would be funded from 1 May 2026 for people who have had a stem cell transplant, as well as a small number of other people with severe immunosuppression who cannot use other funded antiviral medicines. We have heard from clinicians involved in stem cell transplant care and from Pharmac’s cli

Kia ora   The March 2026 edition of Prescriber Update  is now available on the Medsafe website. Please can you share it with your networks.   Kind regards   Medsafe Pharmacovigilance Team